Proteomics of widespread, reversible protein assemblies in aging and aggregation
Proteomics of widespread, reversible protein assemblies in aging and aggregation
批准号:
8184728
负责人:
EDWARD M MARCOTTE
金额:
$36.19万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2015-08-31
关键词:
AffectAgeAge FactorsAgingAlzheimer&aposs DiseaseBiological AssayCell AggregationCell AgingCell Culture TechniquesCellsCellular biologyChimeric ProteinsComplexDependenceDiseaseFluorescence MicroscopyFundingGeneric DrugsGeneticGenetic ScreeningGrantHumanHuman BiologyHuntington DiseaseImageImage AnalysisKineticsLogicLongevityMass Spectrum AnalysisMeasuresMetabolicMicroscopyMothersNatureOrthologous GeneParkinson DiseasePathway interactionsPharmaceutical PreparationsProteinsProteomicsRNARecombinantsRegulationReporterStructureTestingTimeWorkYeastsbasecell agecellular imagingdefined contributiongenome-widehuman diseasenovelprogramsprotein aggregateprotein aggregationresearch studyyeast protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Proteins must organize into complexes that assemble and disassemble depending on cellular needs, while simultaneously avoiding catastrophic aggregation. Such aggregation is critical for important human diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, and perhaps even aging itself. This competitive renewal builds from an observation made in the first funding cycle of grant GM076536 (Cell chips for genome- wide protein and RNA localization in single cells): hundreds of distinct, normally cytosolic protein species form metabolite-induced, reversible, macroscopic punctate foci in quiescent cells of the yeast S. cerevisae. Are these macroscopic assemblies functional or catastrophic? The answers to this question are important for our understanding of quiescent cells and of aggregation-based disease. If these assemblies are functional or contain functional proteins, this represents unexpectedly high levels of organization in quiescent cells, with important ramifications for human cells, which are in the quiescent state for the majority of their lives. If these assemblies represent widespread aggregation, such structures are likely important factors for aging and aggregation-related disease. More generally, might protein aggregation be a novel regulatory mechanism? This grant proposes mass spectrometry proteomics, genetics, cell biology, and imaging experiments to evaluate these hypotheses and to better understand the mechanistic basis for this widespread, reversible protein aggregation. Experiments in Specific Aim I focus on determining kinetics, regulation, and mechanisms of foci formation in yeast cells. Only rarely is there a basic form of regulation in yeast that doesn't exist in humans, and initial tests suggest these foci also form in human cells. Thus, in Aim II, we aim to determine more broadly if these foci, and their regulatory logic, are conserved in human cells and hence likely selected for evolutionarily. Lastly, initial evidence suggests foci formation increases both in replicatively and chronologically aged cells. Experiments in Aim III will define the contribution of foci formation and aggregation towards cellular lifespan, and determine the causal relationship between aggregation and aging. These will provide concrete evidence, on a protein-by-protein basis, either for forming functional protein assemblies in quiescent cells or for catastrophic aggregation. This work will define the extent to which protein foci and aggregates govern survival in quiescent cells and impact cellular lifespan, and is a step towards better understanding of the forces underlying aggregation diseases and aging.
PUBLIC HEALTH RELEVANCE: Proteins must organize into complexes that assemble and disassemble depending on cellular needs, while simultaneously avoiding catastrophic aggregation. Such aggregation is critical for important human diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, and perhaps even aging itself. This grant proposes mass spectrometry proteomics, cell biology and imaging experiments to understand the mechanistic basis for widespread, reversible protein aggregation observed in quiescent cells. This work will increase our understanding of the mechanisms and circumstances under which proteins aggregate, and thus will be a step towards better understanding of the forces underlying aggregation diseases and aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue-specific protein interactome mapping in a vertebrate embryo
-
批准号:10271281
-
项目类别:
-
资助金额:$19.17万
-
财政年份:2020
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Proteomics and model organism humanization to decode human genetics
-
批准号:10558585
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2017
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Proteomics and model organism humanization to decode human genetics
-
批准号:9275630
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2017
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Proteomics and model organism humanization to decode human genetics
-
批准号:10330772
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2017
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Mapping the ciliary interactome, an extensive protein interaction network underlying human ciliopathies
-
批准号:10396638
-
项目类别:
-
资助金额:$57.88万
-
财政年份:2016
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Mapping the CPLANE interactome, an extensive protein interaction network underlying human ciliopathies
-
批准号:9179245
-
项目类别:
-
资助金额:$53.6万
-
财政年份:2016
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Mechansims of Shroom2 function in development and disease
-
批准号:9097892
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2016
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Mapping the ciliary interactome, an extensive protein interaction network underlying human ciliopathies
-
批准号:10211608
-
项目类别:
-
资助金额:$57.88万
-
财政年份:2016
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Mapping the ciliary interactome, an extensive protein interaction network underlying human ciliopathies
-
批准号:10649416
-
项目类别:
-
资助金额:$57.88万
-
财政年份:2016
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Mapping the CPLANE interactome, an extensive protein interaction network underlying human ciliopathies
-
批准号:9535605
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2016
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Next-Generation Proteomics: Massively Parallel Single-Molecule Protein Identifica
-
批准号:8710285
-
项目类别:
-
资助金额:$77.25万
-
财政年份:2012
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Next-Generation Proteomics: Massively Parallel Single-Molecule Protein Identifica
-
批准号:8900316
-
项目类别:
-
资助金额:$77.25万
-
财政年份:2012
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Next-Generation Proteomics: Massively Parallel Single-Molecule Protein Identifica
-
批准号:9117594
-
项目类别:
-
资助金额:$77.25万
-
财政年份:2012
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Next-Generation Proteomics: Massively Parallel Single-Molecule Protein Identifica
-
批准号:8351734
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2012
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Next-Generation Proteomics: Massively Parallel Single-Molecule Protein Identifica
-
批准号:8549276
-
项目类别:
-
资助金额:$74.91万
-
财政年份:2012
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Systematic discovery of nonobvious human disease models by orthologous phenotypes
-
批准号:8308480
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2009
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Systematic discovery of nonobvious human disease models by orthologous phenotypes
-
批准号:7902303
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2009
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Systematic discovery of nonobvious human disease models by orthologous phenotypes
-
批准号:8116444
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2009
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Cell chips for genome-wide protein and RNA localization in single cells
-
批准号:7814783
-
项目类别:
-
资助金额:$14.73万
-
财政年份:2009
-
负责人:EDWARD M MARCOTTE
-
依托单位:
Cell chips for genome-wide protein and RNA localization in single cells
-
批准号:7216837
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2006
-
负责人:EDWARD M MARCOTTE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: